Abstract Number: 344 • 2018 ACR/ARHP Annual Meeting
Use of Lean Six-Sigma Methodologies to Improve Pneumococcal Vaccination Rates Among Immunocompromised Veterans with Rheumatologic Diseases: A Quality Improvement Project
Background/Purpose: Pneumonia is a leading cause of morbidity and mortality in the United States among immunocompromised individuals with rheumatologic diseases. Despite the publication of Advisory…Abstract Number: 466 • 2018 ACR/ARHP Annual Meeting
Improving Pneumococcal Vaccination Rates in Childhood-Onset SLE Patients at a Large Tertiary Care Center: The Path to Creating a More Sustainable Model of Vaccination with the Help of EMR
Background/Purpose: Streptococcus pneumonia is a leading cause of illness in children worldwide and can lead to death in those with an immunosuppressed status. Given the…Abstract Number: 1241 • 2018 ACR/ARHP Annual Meeting
Pneumococcal Vaccination Quality Improvement Initiative within a Rheumatology Clinic at an Academic Medical Center
Background/Purpose: Rheumatology patients are at an increased risk of infection secondary to immunosuppressive medications used for disease management. However, vaccination is underutilized and rates remain…Abstract Number: 2026 • 2017 ACR/ARHP Annual Meeting
Pneumococcal Vaccination Rates: Improving Safety in Immunocompromised Patients
Background/Purpose: Streptococcus pneumoniae is the most common cause of bacterial pneumonia.1 Invasive pneumococcal infections carry a 10% mortality rate, which is higher in the immunosuppressed.1…Abstract Number: 2027 • 2017 ACR/ARHP Annual Meeting
Pre-Visit Planning Improves Pneumococcal Vaccination in Patients with Childhood-Onset Systemic Lupus Erythematosus
Background/Purpose: Patients with Systemic Lupus Erythematosus (SLE) lupus are up to 13 times more likely to develop invasive pneumococcal infections, resulting in increased morbidity and…Abstract Number: 425 • 2016 ACR/ARHP Annual Meeting
Improving Pneumococcal Vaccination Rates for Immunosuppressed Patients in an Academic Rheumatology Clinic
Background/Purpose: Patients with autoimmune conditions have higher rates of pneumococcal disease and they are often immunosuppressed. In 2014, the Advisory Committee on Immunization Practices issued…Abstract Number: 426 • 2016 ACR/ARHP Annual Meeting
Herpes Zoster Vaccine: A Quality Improvement Study in Rheumatoid Arthritis Patients
Herpes Zoster Vaccine: A Quality Improvement Study in Rheumatoid Arthritis Patients Chaudhry, Hina S.; Ostrowski, Rochella A. Division of Allergy, Immunology, and Rheumatology, Loyola University…Abstract Number: 2042 • 2016 ACR/ARHP Annual Meeting
Improving the Overall Pneumococcal Vaccination Rate in Lupus Patients at the Rheumatology Clinic
Background/Purpose: The risk of developing invasive pneumococcal pneumonia is 13 times higher in Lupus patients in comparison with general population. CDC anticipates 7.6 Million-Dollar medical…Abstract Number: 1028 • 2015 ACR/ARHP Annual Meeting
Improving Pneumococcal Immunization Rates Among Immunocompromised Adolescent Patients at a Tertiary Care Children’s Hospital
Background/Purpose: Streptococcus pneumoniae is a leading cause of severe infections, including pneumonia and meningitis, among immunocompromised patients. The administration of both the 13-valent pneumococcal conjugate…Abstract Number: 2502 • 2015 ACR/ARHP Annual Meeting
Implementation of New Pneumococcal Vaccination Recommendations in an Academic Rheumatology Clinic
Background/Purpose: Invasive pneumococcal disease is approximately four times more common among patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) compared to healthy counterparts.…Abstract Number: 2503 • 2015 ACR/ARHP Annual Meeting
Improved Pneumococcal Vaccination in Rheumatoid Arthritis Patients in an Urban Academic Rheumatology Clinic
Background/Purpose: Immunosuppressed patients are at higher risk for infections compared to the general population. Vaccines decrease morbidity and mortality, however vaccination status is not consistently…Abstract Number: 1349 • 2014 ACR/ARHP Annual Meeting
A Decision Support Tool to Improve Herpes Zoster Vaccination Rates Among Patients Starting Biologic Medications
Background/Purpose Herpes zoster infection causes serious morbidity and mortality in immunocompromised patients. Vaccination reduces the risk of zoster infection by up to 40% among patients…Abstract Number: 1345 • 2014 ACR/ARHP Annual Meeting
Improving Pneumococcal Immunization Rates for Patients on Immunosuppressant Medications at an Academic Rheumatology Clinic
Background/Purpose: Patients with rheumatologic diseases are frequently placed on immunosuppressant medications which increase their risk of developing Streptococcus pneumoniae infections. The Advisory Committee on Immunization…Abstract Number: 1343 • 2014 ACR/ARHP Annual Meeting
A Quality Improvement Initiative to Improve Pneumococcal Vaccination Rates in Immunosuppressed Patients
Background/Purpose Patients with autoimmune diseases are at increased risk of complicated infections, and immunomodulating treatment regimens further enhance this risk. Many of these infections,…